The Role of Akt on Arsenic Trioxide Suppression of 3T3-L1 Preadipocyte Dif-Ferentiation

Zhi Xin WANG,Chun Sun JIANG,Lei LIU,Xiao Hui WANG,Hai Jing JIN,Qiao WU,Quan CHEN
DOI: https://doi.org/10.1038/sj.cr.7290305
2005-01-01
Abstract:The present study investigates the molecular details of how arsenic trioxide inhibits preadipocyte differentiation and examines the role of Akt/PKB in regulation of differentiation and apoptosis. Continual exposure of arsenic trioxide, at the clinic achievable dosage that does not induce apoptosis, suppressed 3T3-L1 cell differentiation into fat cells by inhibiting the expression of PPAR gamma and C/EBP alpha and disrupting the interaction between PPAR gamma and RXR alpha, which determines the programming of the adipogenic genes. Interestingly, if we treated the cells for 12 or 24 h and then withdrew arsenic trioxide, the cells were able to differentiate to the comparable levels of untreated cells as assayed by the activity of GAPDH, the biochemical marker of preadipocyte differentiation. Long term treatment blocked the differentiation and the activity of GAPDH could not recover to the comparable levels of untreated cells. Continual exposure of arsenic trioxide caused accumulation in G2/M phase and the accumulation of p21. We found that arsenic trioxide induced the expression and the phosphorylation of Akt/PKB and it inhibited the interaction between Akt/PKB and PPAR gamma. Akt/PKB inhibitor appears to block the arsenic trioxide suppression of differentiation. Our results suggested that Akt/PKB may play a role in suppression of apoptosis and negatively regulate preadipocyte differentiation.
What problem does this paper attempt to address?